Medicines: Nivolumab

Treatment-free survival results of nivolumab and salvage nivolumab + ipilimumab for accRCC

Opdivo (nivolumab) the Immunotherapy Cancer Treatment

Oncology Associates

Dr. Sharpless on Managing Toxicities With Nivolumab/Ipilimumab in Melanoma

Cancer Immunotherapy with Nivolumab Plus Ipilimumab Vs. Chemotherapy: Insights from CheckMate 227

Melanoma Treatment: Nivolumab (Opdivo) vs. Pembrolizumab (Keytruda) | Memorial Sloan Kettering

Memorial Sloan Kettering Cancer Center

Dr. Sznol on Combining Nivolumab and Ipilimumab for the Treatment of Advanced Melanoma

Novel agents for the treatment of Hodgkin lymphoma: brentuximab vedotin and nivolumab

VJHemOnc – Video Journal of Hematology & HemOnc

Investigating Responses to Nivolumab and Ipilimumab in Advanced RCC

Targeted Oncology

Dr. Shoushtari on the Role of Nivolumab and Ipilimumab in Mucosal Melanoma

Should you treat melanoma with nivolumab and relatlimab (Opdualag)?

Success for ipilimumab and nivolumab combo in advanced melanoma

Melanoma Patient Story: Immunotherapy Treatment (Nivolumab/Opdivo) | Rich’s Story (5 of 5)

The Patient Story

Nivolumab improves overall survival for advanced kidney cancer

Nivolumab: A Breakthrough Immunotherapy for Cancer Treatment

Immunotherapy Institute

Five-Year Follow-Up Results for Nivolumab in NSCLC

Targeted Oncology

Immunotherapy Treatments for Non-Small Cell Lung Cancer (NSCLC)

You and Lung Cancer

Melanoma patients who discontinued nivolumab and ipilimumab experienced equal or better PFS

COM701 & nivolumab in patients with metastatic MSS-CRC & liver metastases

New Long-term Data 'Clearly Favor' Combination Ipilimumab/Nivolumab in Melanoma

Nivolumab in Renal Cell Carcinoma